ELECSYS ANTI-HBC IMMUNOASSAY, ELECSYS PRECICONTROL ANTI-HBC FOR USE ON THE ELECSYS 2010 IMMUNOASSAY ANALYZER

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P100032 S013

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Relocation of manufacturing activities for the purification and production of antibodies and proteins and for the lyophilization of raw materials and addition of new lyophilization equipment.

DeviceELECSYS ANTI-HBC IMMUNOASSAY, ELECSYS PRECICONTROL ANTI-HBC FOR USE ON THE ELECSYS 2010 IMMUNOASSAY ANALYZER
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantROCHE DIAGNOSTICS CORP.
Date Received2016-02-16
Decision Date2016-03-16
PMAP100032
SupplementS013
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250

Supplemental Filings

Supplement NumberDateSupplement Type
P100032Original Filing
S021 2021-09-30 Normal 180 Day Track
S020 2018-10-26 Normal 180 Day Track No User Fee
S019 2018-10-09 30-day Notice
S018 2018-03-01 Real-time Process
S017 2017-10-11 Real-time Process
S016 2017-08-03 30-day Notice
S015 2017-05-24 30-day Notice
S014 2017-02-21 Normal 180 Day Track
S013 2016-02-16 30-day Notice
S012 2016-01-27 30-day Notice
S011 2016-01-27 135 Review Track For 30-day Notice
S010 2015-10-07 30-day Notice
S009 2013-04-09 Real-time Process
S008 2012-11-30 30-day Notice
S007 2012-09-04 Normal 180 Day Track
S006 2012-02-29 30-day Notice
S005 2012-01-31 135 Review Track For 30-day Notice
S004 2011-08-29 135 Review Track For 30-day Notice
S003 2011-08-17 Normal 180 Day Track No User Fee
S002 2011-08-17 135 Review Track For 30-day Notice
S001 2011-07-01 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.